Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Sight Sciences Inc (SGHT)

  • Business News
  • Sept. 02, 2025, 20:06 UTC
  • 8
  • 0 comments

Sight Sciences Announces Recognition of theTearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

Market reaction Comment Full text

Teladoc Inc (TDOC)

  • SEC News
  • Sept. 02, 2025, 20:06 UTC
  • 3
  • 0 comments

New Form 144 - Teladoc Health, Inc. Filed: 2025-09-02 AccNo: 0001959173-25-005703 Size: 5 KB

Comment Full text

Akebia Therapeutics Inc (AKBA)

  • Business News
  • Sept. 02, 2025, 20:06 UTC
  • 7
  • 0 comments

Akebia Therapeutics Reports Inducement GrantsUnder Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Quince Therapeutics Inc (QNCX)

  • Business News
  • Sept. 02, 2025, 20:06 UTC
  • 7
  • 0 comments

Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference

Market reaction Comment Full text

Oncology Institute Inc (TOI)

  • Business News
  • Sept. 02, 2025, 20:06 UTC
  • 8
  • 0 comments

The Oncology Institute Launches Lung Cancer Center of Excellence in Florida Led by International Oncology Expert Dr. Edgardo Santos

Market reaction Comment Full text

ADC Therapeutics SA (ADCT)

  • Business News
  • Sept. 02, 2025, 20:06 UTC
  • 7
  • 0 comments

ADC - ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Market reaction Comment Full text

Alto Ingredients Inc (ALTO)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 6
  • 0 comments

Alto Ingredients, Inc. to Present in the 27th Annual H.C. Wainwright Global Investment Conference

Market reaction Comment Full text

Arcus Biosciences Inc. (RCUS)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 7
  • 0 comments

Arcus Biosciences - Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation

Market reaction Comment Full text

Health Catalyst Inc (HCAT)

  • SEC News
  • Sept. 02, 2025, 20:05 UTC
  • 3
  • 0 comments

New Form 144 - Health Catalyst, Inc. Filed: 2025-09-02 AccNo: 0001636422-25-000126 Size: 4 KB

Comment Full text

Arcus Biosciences Inc. (RCUS)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 7
  • 0 comments

Arcus Biosciences to Host Investor Event to Highlight its Late-Stage Casdatifan Program and Next Wave of Programs Focused on Inflammation

Market reaction Comment Full text

Tenaya Therapeutics Inc (TNYA)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 5
  • 0 comments

Tenaya Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Market reaction Comment Full text

Karyopharm Therapeutics Inc (KPTI)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 7
  • 0 comments

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

Protara Therapeutics Inc. (TARA)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 7
  • 0 comments

Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

ADC Therapeutics SA (ADCT)

  • Business News
  • Sept. 02, 2025, 20:05 UTC
  • 3
  • 0 comments

ADC Therapeutics Makes Grants to New Employees Under Inducement Plan

Market reaction Comment Full text

InnovAge Holding Corp (INNV)

  • SEC News
  • Sept. 02, 2025, 20:05 UTC
  • 5
  • 1 comments

BLAIR PATRICK T 🔴 sold 5.1K shares of InnovAge Holding Corp. (INNV) at $3.83 Transaction Date: Sep 01, 2025 | Filing ID: 000055

Comment Full text
  • Previous
  • 379
  • 380
  • 381
  • 382
  • 383
  • Next

Search

News categories

  • Technical Exchange News(10123)
  • Event(435)
  • SEC News(171172)
  • FDA Approval(9501)
  • Company Report(721)
  • Business News(114111)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin